Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882232 · ClinicalTrials.gov registry record · Phase 1
Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer
A Phase 1 study, sponsored by Cancer Center of Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00882232: Completed Phase 1 study, sponsored by Cancer Center of Irvine.
NCT00882232 is a Phase 1 study that has completed, run by Cancer Center of Irvine. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00882232, a Phase 1 study, has completed, sponsored by Cancer Center of Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if cross-linked hyaluronan gel reduces the dose of radiation delivered to the rectum and the rectal toxicity of radiotherapy for localized prostate cancer.
Interventions
- DEVICE Cross-linked hyaluronan gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
What the finished NCT00882232 record still lists
NCT00882232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Cross-linked hyaluronan gel is the first listed.
NCT00882232 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00882232 about?
NCT00882232 is a clinical study titled "Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer". The primary purpose of this study is to determine if cross-linked hyaluronan gel reduces the dose of radiation delivered to the rectum and the rectal toxicity of radiotherapy for localized prostate cancer.
What is the current status of trial NCT00882232?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00882232?
The interventions under investigation include: Cross-linked hyaluronan gel (DEVICE).
Who is sponsoring clinical trial NCT00882232?
This trial is sponsored by Cancer Center of Irvine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00882232's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia